Bed space for short term stay at Diagnostic & Consultative Centre 'Ascendent' Ltd. — Clinical Trial Site

11 Registered trials

0 Currently recruiting

Organisation

Bed space for short term stay at Diagnostic & Consultative Centre 'Ascendent' Ltd.

Location

Sofia, Bulgaria

Identifier

ORL-000001192

Address

47 'Bacho Kiro' str., 1202, Bulgaria

Departments

Bed space for short term stay
Diagnostic & Consultative Centre 'Ascendent' Ltd.

Clinical trials at this site (11)

Search interface

Evaluation of bioequivalence of two products containing estradiol: Estradiol/INTERMED gel 0.1% w/w (Test) vs. ESTREVA 0.1% gel (Comparator).… Pending

2025-524775-23-00 No therapeutic indication in the current trial with hea 2
Bioavailability study with naloxone hydrochloride in healthy volunteers Ended

2024-517838-17-00 No therapeutic indication in the current trial with hea 2 2026-03-06
Evaluation of the bioequivalence of two products containing esomeprazole under fasting conditions: Esomeprazole-Syrup 40 mg dose (Test) vs. … Ended

2024-512401-89-00 No therapeutic indication in the current trial with hea 2 2025-06-12
Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTE… Ended

2024-517969-16-00 No therapeutic indication in the current trial with hea 3 2025-03-12
Evaluation of the bioequivalence of two products containing esomeprazole under fed conditions: Esomeprazole-Syrup 40 mg dose (Test) vs. Nexi… Ended

2024-512674-97-00 No therapeutic indication in the current trial with hea 2 2025-03-11
A study to compare two different aramchol formulations in healthy volunteers. Ended

2023-507445-28-00 Nonalcoholic fatty liver disease 3 2024-12-18
Evaluation of the bioavailability of two products containing esomeprazole under fasting and fed conditions: Esomeprazole-Syrup 40 mg dose (T… Ended

2023-506701-18-00 No therapeutic indication in the current trial with hea 3 2024-03-27
Bioequivalence of Cladribine 10 mg from two different products Ended

2023-508656-19-00 No therapeutic indication in the current trial with hea 2 2024-03-01
An open label, randomized, four-period, four-sequence single dose, crossover trial in healthy volunteers to determine the relative bioavaila… Ended

2022-502420-51-00 No therapeutic indication in the current trial with hea 2 2023-10-23
A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered via Levodopa Cyclops™ (test product) R… Ended

2023-504687-42-00 No therapeutic indication in the current trial with hea 3 2023-09-19
Single dose oral bioequivalence study of Cladribine 10 mg Tablets and Mavenclad® 10 mg tablets (Cladribine) in healthy adult human subjects … Ended

2025-522252-74-00 No therapeutic indication in the current trial with hea 2